Status:
COMPLETED
Increasing Documentation and Disclosure of Sickle Cell Trait Status: An Implementation Science Approach
Lead Sponsor:
Nemours Children's Clinic
Conditions:
Sickle Cell Trait
Eligibility:
All Genders
Phase:
NA
Brief Summary
The hemoglobinopathy newborn screen (NBS) performed on all neonates in the U.S. allows for early life-saving medical care for infants with sickle cell disease (SCD), an autosomal recessive genetic dis...
Eligibility Criteria
Inclusion
- Outpatient pediatric primary care providers within Nemours and their patients
Exclusion
- none
Key Trial Info
Start Date :
January 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT05387564
Start Date
January 18 2024
End Date
December 30 2024
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nemours Children's Hospital, Delware
Wilmington, Delaware, United States, 19803